Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

Aslan Fred sold 23,429 Artiva Biotherapeutics, Inc. shares (Form 4)

Traded Sep 8, 2026 · Filed Sep 9, 2026

On Sep 8, 2026, Aslan Fred (Director, Chief Executive Officer) sold 23,429 Artiva Biotherapeutics, Inc. shares at US$10.92 for US$256K under a trading plan, leaving 1,449,765 shares. Filed Sep 9, 2026 (Form 4).

Sold
23,429 shares
Price
US$10.92
Value
US$256K
Holding after
1,449,765 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 8, 2026Common StockSale23,429US$10.921,449,765Direct

Source

View original at SEC

Related